SCHEMBL6813286

SCHEMBL6813286

CC(=O)N[C@H](C)C(=O)NCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.64
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
CA3 P07451 1/20 0.64
CA4 P22748 1/20 0.64
CA6 P23280 1/20 0.64
CA5A P35218 1/20 0.64
CA7 P43166 1/20 0.64
CACNA1C Q13936 1/20 0.64
SCN9A Q15858 1/20 0.64
CA9 Q16790 1/20 0.64
CA13 Q8N1Q1 1/20 0.64
CA14 Q9ULX7 1/20 0.64
CA5B Q9Y2D0 1/20 0.64
MMP8 P22894 1/20 0.62
ALDH1A1 P00352 4/20 0.58
KMT2A Q03164 2/20 0.58
MME P08473 1/20 0.57
MAPT P10636 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6814514 1.00 CA12 (0.64) CA12CA1CA2CA3CA4
SCHEMBL993570 1.00 CA12 (0.64) CA12CA1CA2CA3CA4
SCHEMBL24347010 0.97 MMP8 (0.63) CA12CA1CA2CA3CA4
SCHEMBL25214759 0.88 MMP8 (0.63) CA12CA1CA2CA3CA4
SCHEMBL25214750 0.88 MMP8 (0.63) CA12CA1CA2CA3CA4
SCHEMBL25240460 0.88 MMP8 (0.63) CA12CA1CA2CA3CA4
SCHEMBL12436634 0.87 MMP8 (0.59) CA12CA1CA2CA3CA4
SCHEMBL24345983 0.85 MMP8 (0.54) CA12CA1CA2CA3CA4
SCHEMBL8545637 0.85 CA12 (0.66) CA12CA1CA2CA3CA4
SCHEMBL24347008 0.84 MMP8 (0.63) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38551-E1 ADMINISTERING N-BENZYL-2- ACETAMIDO PROPIONAMIDE DERIVATIVES IN THE R CONFIGURATION, SUCH AS LACOSAMIDE RESEARCH CORPORATION TECHNOLOGIES, INC. 2004-07-06 US disclosed
EP-1038522-B1 Anticonvulsant enantiomeric amino acid derivatives RES CORP TECHNOLOGIES INC (US) 2004-06-02 EP disclosed
EP-0400440-B1 Amino acid derivative anticonvulsant RES CORP TECHNOLOGIES INC (US) 2002-03-13 EP disclosed
EP-0888289-B1 ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES RES CORP TECHNOLOGIES INC (US) 2001-06-13 EP disclosed
EP-1038522-A2 Anticonvulsant enantiomeric amino acid derivatives Research Corporation Technologies, Inc (US) 2000-09-27 EP disclosed
EP-0888289-A1 ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES Research Corporation Technologies, Inc (US) 1999-01-07 EP disclosed
US-5773475-A DIPEPTIDES FOR CENTRAL NERVOUS SYSTEM DISORDERS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1998-06-30 US disclosed
WO-1997033861-A1 ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1997-09-18 WO disclosed
US-5654301-A Lacosamide FDA Orange book listed patent RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1997-08-05 US disclosed
US-5378729-A Diamide derivatives RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-01-03 US disclosed
WO-1992021648-A1 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1992-12-10 WO disclosed
WO-1990015069-A2 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1990-12-13 WO disclosed
EP-0400440-A1 Amino acid derivative anticonvulsant RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1990-12-05 EP disclosed